logo-loader
Wayland Group Inc

Maricann to rename itself as Wayland Group as it looks to widen its reach in cannabis

Maricann’s renaming to Wayland Group comes amid the widening of its outreach efforts for both its medical and non-medical cannabis brands

cultivation of medical marijuana
Maricann will call itself Wayland Group and trade under the ticker symbol WAYL starting tomorrow

The Canadian medical marijuana group Maricann Group Inc (CSE:MARI, OTCQB:MRRCF) has unveiled plans to change its name to Wayland Group Corp and to begin trading under the ticker symbol WAYL starting tomorrow.

Maricann’s renaming to Wayland Group comes as part of its global expansion and the widening of its outreach efforts for both its medical and non-medical cannabis brands.

“The new name reflects the more expansive portfolio that we’ve built and the direction that we’re heading as a global cannabis company,” said CEO Ben Ward.

Headquartered in Burlington, Ontario and Munich, Germany, Maricann distributes marijuana for medical purposes, offering a variety of oil and flower products.

It has production facilities in Langton, Ontario, where it operates a medicinal cannabis cultivation, extraction and distribution business under a license from the Government of Canada. It also maintains production operations in Dresden, Germany and Regensdorf, Switzerland.

Maricann’s proposed name change to Wayland is subject to the approval of its shareholders who are expected to vote on the proposal at a meeting later this year.

Maricann shares slipped 0.44% to C$2.24 in Monday’s afternoon session.

Quick facts: Wayland Group Inc

Price: $0.74

Market: CSE
Market Cap: $67.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

1 day, 9 hours ago

2 min read